PPD offers a broad range of early development services, Phase I clinical trial services and nonclinical consulting.
Extensive knowledge of hematology and oncology research, vast capabilities and experience with feasibility studies and a large investigator network.
PPD's Phase I Clinic conducts clinical studies to determine how new medicines act in the bodies of healthy volunteers.
Get information about PPD posted on industry websites and publications.
Tina Bostic, executive director, pharmacovigilance, discusses PPD’s outsourcing strategy through expanding the global labor force.
Within pharmacovigilance at PPD, we have implemented various artificial intelligence and machine learning methods that help us and our clients achieve better results.
Gary Barker, Denise Moody, Magda Santos and April Pierce provide insight into creating and keeping a successful pharmacovigilance partnership with a functional service provider.
© 2019 Pharmaceutical Product Development, LLC. All rights reserved.